At the news
? MIXEDIMPACT 5/10 CLUSTER filed Apr 2, 2026 at 16:36 ET
Three corporate insiders at United Therapeutics, including CEO Martine Rothblatt and CFO James Edgemond, conducted open-market sales totaling $1.08 million over a 7-day window, following a series of derivative exercises. The sales are modest in absolute value but involve key executives, raising questions about intent despite no clear signs of distress.
- CEO Martine Rothblatt sold 1,300 shares for $725K in open-market transactions across multiple days (April 6–9, 2026).
- CFO James Edgemond sold 680 shares for $388K, including a $322K sale on April 9.
- EVP & General Counsel Paul Mahon sold 514 shares for $288K on April 2.
- Total open-market sales: $1.08M, representing 0.0043% of the company's $25.2B market cap.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access